These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Microalbuminuria is an early marker for increased morbidity and mortality]. Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947 [TBL] [Abstract][Full Text] [Related]
8. Drug treatment for hypertensive patients in special situations: diabetes and hypertension. Mogensen CE Clin Exp Hypertens; 1999; 21(5-6):895-906. PubMed ID: 10423111 [TBL] [Abstract][Full Text] [Related]
9. Microalbuminuria in Thai essential hypertensive patients. Buranakitjaroen P; Phoojaroenchanachai M; Saravich S J Int Med Res; 2007; 35(6):836-47. PubMed ID: 18034997 [TBL] [Abstract][Full Text] [Related]
10. Influence of microalbuminuria in achieving blood pressure goals. Duka I; Bakris G Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385 [TBL] [Abstract][Full Text] [Related]
11. Relation of short-term blood pressure variability to early renal effects in hypertensive patients with controlled blood pressure. Farrag HMA; Amin AS; Abdel-Rheim AR Blood Press Monit; 2019 Oct; 24(5):221-224. PubMed ID: 31116153 [TBL] [Abstract][Full Text] [Related]
12. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects. Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397 [TBL] [Abstract][Full Text] [Related]
13. Hypertension and microalbuminuria: the new detrimental duo. Verdecchia P; Reboldi GP Blood Press; 2004; 13(4):198-211. PubMed ID: 15581333 [TBL] [Abstract][Full Text] [Related]
14. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria. Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229 [TBL] [Abstract][Full Text] [Related]
15. [Control of arterial pressure in diabetic nephropathy]. Luño J; García de Vinuesa S Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304 [No Abstract] [Full Text] [Related]
16. Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Ruilope LM; Alcázar JM; Hernández E; Praga M; Lahera V; Rodicio JL Kidney Int Suppl; 1994 Feb; 45():S171-3. PubMed ID: 7908997 [No Abstract] [Full Text] [Related]
17. Regression of albuminuria: latest evidence for a new approach. Viberti G J Hypertens Suppl; 2003 Jun; 21(3):S24-8. PubMed ID: 12929472 [TBL] [Abstract][Full Text] [Related]
18. Microalbuminuria in hypertensive patients: evaluation of one-year treatment with irbesartan. de Alvaro F; Velasco O; Honorato J; Calvo C; Parrondo I; Kidney Int Suppl; 2005 Jan; (93):S29-34. PubMed ID: 15613064 [TBL] [Abstract][Full Text] [Related]
19. Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the nordic diltiazem study. Färbom P; Wahlstrand B; Almgren P; Skrtic S; Lanke J; Weiss L; Kjeldsen S; Hedner T; Melander O Hypertension; 2008 Jul; 52(1):115-22. PubMed ID: 18504324 [TBL] [Abstract][Full Text] [Related]
20. Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy. Alli C; Lombardo M; Zanni D; Agrati AM; Cassani M; Granata S Am J Hypertens; 1996 Nov; 9(11):1068-76. PubMed ID: 8931831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]